APA (7th ed.) Citation

A, M., MJ, F., C, V., E, V., & JJ, A. (2025). Use of sarilumab in VEXAS syndrome. Rheumatology (Oxford, England), 64(2), 890. https://doi.org/10.1093/rheumatology/keae068

Chicago Style (17th ed.) Citation

A, Mayo-Juanatey, Fernández-Llavador MJ, Valera-Ribera C, Valls-Pascual E, and Alegre-Sancho JJ. "Use of Sarilumab in VEXAS Syndrome." Rheumatology (Oxford, England) 64, no. 2 (2025): 890. https://doi.org/10.1093/rheumatology/keae068.

MLA (9th ed.) Citation

A, Mayo-Juanatey, et al. "Use of Sarilumab in VEXAS Syndrome." Rheumatology (Oxford, England), vol. 64, no. 2, 2025, p. 890, https://doi.org/10.1093/rheumatology/keae068.